A large-scale screen to target SARS-CoV-2 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome is initially expressed as two large polyproteins. Its main protease, M pro , is essential to yield functional viral proteins, making it a key drug target. Günther et al. used x-ray crystallography to screen more than 5000 compounds that are either approved drugs or drugs in clinical trials. The screen identified 37 compounds that bind to M pro . High-resolution structures showed that most compounds bind at the active site but also revealed two allosteric sites where binding of a drug causes conformational changes that affect the active site. In cell-based assays, seven compounds had antiviral activity without toxicity. The most potent, calpeptin, binds covalently in the active site, whereas the second most potent, pelitinib, binds at an allosteric site. Science , this issue p. 642 A repurposed drug-library screen reveals two allosteric drug binding sites of the SARS-CoV-2 main protease. The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID-19, we have performed a high-throughput x-ray crystallographic screen of two repurposing drug libraries against the SARS-CoV-2 main protease (M pro ), which is essential for viral replication. In contrast to commonly applied x-ray fragment screening experiments with molecules of low complexity, our screen tested already-approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds that bind to M pro . In subsequent cell-based viral reduction assays, one peptidomimetic and six nonpeptidic compounds showed antiviral activity at nontoxic concentrations. We identified two allosteric binding sites representing attractive targets for drug development against SARS-CoV-2.
【초록키워드】 COVID-19, coronavirus disease, Structure, SARS-CoV-2, coronavirus, Genome, clinical trials, Toxicity, Viral proteins, drug, protease, antiviral activity, binding site, Protein, viral replication, drug target, target, experiment, binding, structures, conformational change, Science, reduction, approved drug, acute respiratory syndrome, Compound, M pro, treat, drug library, polyproteins, Affect, effective, concentrations, Seven, bind, tested, performed, caused, assays, subsequent, the disease, applied, functional, expressed, cause, representing, reveal, creating, nontoxic, the SARS-CoV-2, 【제목키워드】 protease, X-ray, inhibitors of SARS-CoV-2, identify,